Insights

US Leadership Aurobindo is a leading US generic pharma player with a broad, globally approved manufacturing footprint. Its USFDA and other regulatory approvals underpin reliable supply, enabling opportunities for exclusive US distribution, multi-country tenders, and API/CMO partnerships to serve growing demand for affordable generics.

Biologics Expansion The TheraNym biologics CMO facility in Telangana, backed by a Rs 1,200 crore investment and anchored by MSD, positions Aurobindo for end-to-end biologics development and manufacturing, including scalable fill-finish for biosimilars and early-stage programs.

NCE Licensing The announced Otsuka-licensed NCE for atopic dermatitis in the US presents licensing, co-development, or exclusive distribution opportunities, leveraging Aurobindo's dermatology focus and capacity to support large-scale partnerships.

Strategic Capacity Capacity expansion in India for biologics and other facilities enhances regional and global supply resilience, enabling contract manufacturing, fill-finish, and development partnerships with regional distributors and global pharma.

Diversified Reach With a portfolio across eight therapeutic areas and a footprint in over 150 countries, Aurobindo offers cross-sell opportunities, multi-country tenders, and bundled API-to-finished-dose offerings to distributors, hospitals, and manufacturers seeking a scalable partner.

Similar companies to AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD Tech Stack

AUROBINDO PHARMA LTD uses 8 technology products and services including Power BI, cdnjs, Cloudflare, and more. Explore AUROBINDO PHARMA LTD's tech stack below.

  • Power BI
    Business Intelligence
  • cdnjs
    Content Delivery Network
  • Cloudflare
    Content Management System
  • Open Graph
    Content Management System
  • Microsoft Office
    Office Suites
  • Ubuntu
    Operating Systems
  • Apache
    Web Servers
  • Nginx
    Web Servers

Media & News

AUROBINDO PHARMA LTD's Email Address Formats

AUROBINDO PHARMA LTD uses at least 1 format(s):
AUROBINDO PHARMA LTD Email FormatsExamplePercentage
First.Last@aurobindo.comJohn.Doe@aurobindo.com
92%
FLast@aurobindo.comJDoe@aurobindo.com
5%
First_Last@aurobindo.comJohn_Doe@aurobindo.com
2%
First@aurobindo.comJohn@aurobindo.com
1%

Frequently Asked Questions

Where is AUROBINDO PHARMA LTD's headquarters located?

Minus sign iconPlus sign icon
AUROBINDO PHARMA LTD's main headquarters is located at Gachibowli, Telangana 500032 India. The company has employees across 6 continents, including AsiaNorth AmericaEurope.

What is AUROBINDO PHARMA LTD's official website and social media links?

Minus sign iconPlus sign icon
AUROBINDO PHARMA LTD's official website is aurobindo.com and has social profiles on LinkedIn.

What is AUROBINDO PHARMA LTD's NAICS code?

Minus sign iconPlus sign icon
AUROBINDO PHARMA LTD's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does AUROBINDO PHARMA LTD have currently?

Minus sign iconPlus sign icon
As of May 2026, AUROBINDO PHARMA LTD has approximately 15K employees across 6 continents, including AsiaNorth AmericaEurope. Key team members include Ceo-Europe: V. M. M.Chief Executive Officer: R. A.Chief Executive Officer: A. R.. Explore AUROBINDO PHARMA LTD's employee directory with LeadIQ.

What industry does AUROBINDO PHARMA LTD belong to?

Minus sign iconPlus sign icon
AUROBINDO PHARMA LTD operates in the Pharmaceutical Manufacturing industry.

What technology does AUROBINDO PHARMA LTD use?

Minus sign iconPlus sign icon
AUROBINDO PHARMA LTD's tech stack includes Power BIcdnjsCloudflareOpen GraphMicrosoft OfficeUbuntuApacheNginx.

What is AUROBINDO PHARMA LTD's email format?

Minus sign iconPlus sign icon
AUROBINDO PHARMA LTD's email format typically follows the pattern of First.Last@aurobindo.com. Find more AUROBINDO PHARMA LTD email formats with LeadIQ.

When was AUROBINDO PHARMA LTD founded?

Minus sign iconPlus sign icon
AUROBINDO PHARMA LTD was founded in 1986.

AUROBINDO PHARMA LTD

Pharmaceutical ManufacturingTelangana, India10001+ Employees

Aurobindo Pharma Limited is an integrated global pharmaceutical company headquartered in Hyderabad, Telangana, India. It develops, manufactures, and markets a broad range of generic medicines, branded specialty drugs, and active pharmaceutical ingredients for markets in more than 150 countries. The company is a major player in the generic space, with a substantial footprint in the United States where it is the largest generic pharmaceutical company, and a presence in Europe where it ranks in the top 10 in several countries. Its manufacturing and packaging network comprises multiple facilities approved by major regulators, including USFDA, UK MHRA, EDQM, PMDA, WHO, Health Canada, MCC, and ANVISA. The portfolio spans eight therapeutic areas—CNS, antiretrovirals, cardiovascular, antibiotics, gastroenterology, anti-diabetics, oncology, and dermatology—and is supported by a robust research and development framework. In June 2026, Aurobindo announced plans to develop a major biologics contract manufacturing facility in Telangana, with MSD Pharma named as anchor client, marking an expansion into biologics manufacturing.

Section iconCompany Overview

Headquarters
Gachibowli, Telangana 500032 India
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1986
Employees
10001+

Section iconFunding & Financials

  • $1B$10B

    AUROBINDO PHARMA LTD's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $1B$10B

    AUROBINDO PHARMA LTD's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.